The objective of this guideline is to present the complete set of all WHO recommendations and best practice statements relating to abortion. While legal, regulatory, policy and service-delivery contexts may vary from country to country, the recommendations and best practices described in this docume...nt aim to enable evidence-based decision-making with respect to quality abortion care.
This guideline updates and replaces the recommendations in all previous WHO guidelines on abortion care
more
Volume 20, September
Global smart update
A new frontier for integrated care.
Until now, most efforts to promote integrated care have focused on bridging the gaps between health and social care or between primary and secondary care. But the NHS five year forward view has highlighted a third dimension – bringing together physical and ment...al health. This report makes a compelling case for this ‘new frontier’ for integration. It gives service users’ perspectives on what integrated care would look like and highlights ten areas that offer some of the biggest opportunities for improving quality and controlling costs.
more
Menthol in tobacco products
Настоящая брошюра посвящена организации наркологической помощи женщинам с учетом их особых потребностей. Она подготовлена в рамках проекта Управления Организац...и Объединенных Наций по наркотикам и преступности (ЮНОДК) по содействию развитию и совершенствованию наркологических служб на основе материалов специальной литературы и тематических исследований, которые подтверждают практический опыт, полученный в процессе оказания наркологических услуг в различных регионах мира.
more
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...nterventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
more
Élargir l’accès aux soins pour
lutter contre les troubles mentaux,
neurologiques et liés à l’utilisation
de substances psychoactives
The new treaty aims at eliminating all forms of illicit trade in tobacco products. It provides tools for preventing illicit trade by securing the supply chain, including by establishing an international tracking and tracing system, by countering illicit trade through dissuasive law enforcement measu...res and a suite of measures to enable international cooperation.
more
Rapport mondial sur les drogues 2018
UNICEF trucks water to the camps where people displaced by the conflict have temporarily settled. UNICEF also installed latrines, showers and water storage tanks in the camps and distributed family hygiene kits to protect children against waterborne diseases.
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Overview
Learning objectives
• Promote respect and dignity for people with psychoses.
• Name common presentations of psychoses.
• Name assessment principles of psychoses.
• Name management principles of psychoses.
• Perform an assessment for psychoses.
• Use effective communicatio...n skills when interacting with a person psychoses.
• Assess and manage physical health concerns in psychoses.
• Assess and manage emergency presentations of psychoses.
• Provide psychosocial interventions to persons with psychoses and their carers.
• Deliver pharmacological interventions as needed and appropriate in psychoses
considering special populations.
• Plan and performs follow-up sessions for people with psychoses.
• Refer to specialist and links with outside agencies for psychoses as appropriate and
available.
more
World Drug Report 2018
-2-
World Drug Report 2018
-3-
Harm reduction: evidence, impacts and challenges
-10-